{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:49:58Z","timestamp":1778874598745,"version":"3.51.4"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T00:00:00Z","timestamp":1196812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001258","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T00:00:04Z","timestamp":1196812804000},"page":"e1258","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["A Novel and Lethal De Novo LQT-3 Mutation in a Newborn with Distinct Molecular Pharmacology and Therapeutic Response"],"prefix":"10.1371","volume":"2","author":[{"given":"John R.","family":"Bankston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minerva","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Spyres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2007,12,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1172\/JCI25537","article-title":"Long QT syndrome: from channels to cardiac arrhythmias.","volume":"115","author":"AJ Moss","year":"2005","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.106.635268","article-title":"Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.","volume":"114","author":"M Vatta","year":"2006","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.106.659086","article-title":"SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome.","volume":"116","author":"A Medeiros-Domingo","year":"2007","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1542-474X.2005.00077.x","article-title":"Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.","volume":"10","author":"AJ Moss","year":"2005","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/3-540-29715-4_11","article-title":"Mutation-specific pharmacology of the long QT syndrome.","author":"RS Kass","year":"2006","journal-title":"Handb Exp Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.hrthm.2007.03.035","article-title":"Cardiac arrhythmias of genetic origin are important contributors to sudden infant death syndrome.","volume":"4","author":"PJ Schwartz","year":"2007","journal-title":"Heart Rhythm"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/CIRCULATIONAHA.106.658021","article-title":"Prevalence of long-QT syndrome gene variants in sudden infant death syndrome.","volume":"115","author":"M Arnestad","year":"2007","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/CIRCULATIONAHA.106.646513","article-title":"Cardiac sodium channel dysfunction in sudden infant death syndrome.","volume":"115","author":"DW Wang","year":"2007","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.eupc.2004.09.007","article-title":"Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias.","volume":"7","author":"AD Ten Harkel","year":"2005","journal-title":"Europace"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/hc3501.095361","article-title":"De novo mutation in the SCN5A gene associated with early onset of sudden infant death.","volume":"104","author":"H Wedekind","year":"2001","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/heart.90.1.13","article-title":"Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response.","volume":"90","author":"E Schulze-Bahr","year":"2004","journal-title":"Heart"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/23034","article-title":"Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia.","volume":"400","author":"CE Clancy","year":"1999","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1469-7793.1997.345bb.x","article-title":"Role in fast inactivation of the IV\/S4-S5 loop of the human muscle Na+ channel probed by cysteine mutagenesis.","volume":"505 (Pt 2)","author":"H Lerche","year":"1997","journal-title":"J Physiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.","volume":"92","author":"PJ Schwartz","year":"1995","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/01.CIR.101.14.1698","article-title":"Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?","volume":"101","author":"J Benhorin","year":"2000","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.bjp.0706709","article-title":"Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.","volume":"148","author":"S Fredj","year":"2006","journal-title":"Br J Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0026-895X(24)26447-6","article-title":"Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide.","volume":"57","author":"T Nagatomo","year":"2000","journal-title":"Mol Pharmacol"},{"key":"ref18","first-page":"199","article-title":"Common molecular determinants of flecainide and lidocaine block of heart na(+) channels: evidence from experiments with neutral and quaternary flecainide analogues.","volume":"121","author":"H Liu","year":"2003","journal-title":"JGenPhysiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000069273.51375.BD","article-title":"Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia.","volume":"107","author":"CE Clancy","year":"2003","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI119335","article-title":"Pharmacological Targeting of Long QT Mutant Sodium Channels.","volume":"99","author":"DW Wang","year":"1997","journal-title":"Journal of Clinical Investigation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI0215928","article-title":"Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.","volume":"110","author":"CE Clancy","year":"2002","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"H1573","DOI":"10.1152\/ajpheart.00794.2003","article-title":"A model for human ventricular tissue.","volume":"286","author":"KH ten Tusscher","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJM200007273430405","article-title":"A molecular link between the sudden infant death syndrome and the long-QT syndrome.","volume":"343","author":"PJ Schwartz","year":"2000","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00246-002-0169-5","article-title":"Congenital long QT syndrome and 2:1 atrioventricular block with a mutation of the SCN5A gene.","volume":"24","author":"M Miura","year":"2003","journal-title":"Pediatr Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1172\/JCI25618","article-title":"A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y.","volume":"116","author":"LD Plant","year":"2006","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1161\/01.CIR.0000128874.43908.CA","article-title":"Images in cardiovascular medicine. Life-threatening neonatal arrhythmia: successful treatment and confirmation of clinically suspected extreme long QT-syndrome-3.","volume":"109","author":"H Kehl","year":"2004","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1001\/jama.286.18.2264","article-title":"Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.","volume":"286","author":"MJ Ackerman","year":"2001","journal-title":"Jama"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1001\/jama.294.23.2975","article-title":"Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice.","volume":"294","author":"C Napolitano","year":"2005","journal-title":"Jama"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/01.CIR.97.7.640","article-title":"Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel.","volume":"97","author":"NG Kambouris","year":"1998","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/376683a0","article-title":"Molecular mechanism for an inherited cardiac arrhythmia.","volume":"376","author":"PB Bennett","year":"1995","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/hh0701.089668","article-title":"Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.","volume":"88","author":"H Abriel","year":"2001","journal-title":"Circ Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1097-4695(199810)37:1<37::AID-NEU4>3.0.CO;2-9","article-title":"Regulation of voltage-gated K+ channel expression in the developing mammalian myocardium.","volume":"37","author":"JM Nerbonne","year":"1998","journal-title":"J Neurobiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0008-6363(03)00360-2","article-title":"Developmental changes in IKr and IKs contribute to age-related expression of dofetilide effects on repolarization and proarrhythmia.","volume":"59","author":"MN Obreztchikova","year":"2003","journal-title":"Cardiovasc Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/jmcc.2000.1327","article-title":"Alternation of inwardly rectifying background K+ channel during development of rat fetal cardiomyocytes.","volume":"33","author":"M Nagashima","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1006\/jmcc.1996.0084","article-title":"Comparison of the effects of class I anti-arrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes.","volume":"28","author":"DW Wang","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjp.0704784","article-title":"Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.","volume":"136","author":"AA Paul","year":"2002","journal-title":"Br J Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4065\/78.12.1479","article-title":"Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome.","volume":"78","author":"MJ Ackerman","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2125.2005.02545.x","article-title":"Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore.","volume":"61","author":"SH Koo","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0008-6363(03)00458-9","article-title":"Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG).","volume":"59","author":"KJ Paavonen","year":"2003","journal-title":"Cardiovasc Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(03)00342-0","article-title":"A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization.","volume":"59","author":"CR Bezzina","year":"2003","journal-title":"Cardiovasc Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"H2434","DOI":"10.1152\/ajpheart.00891.2003","article-title":"Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels.","volume":"286","author":"BD Anson","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/CIRCULATIONAHA.105.549071","article-title":"KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.","volume":"112","author":"L Crotti","year":"2005","journal-title":"Circulation"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients.","volume":"116","author":"Y Ruan","year":"2007","journal-title":"Circulation"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T06:45:41Z","timestamp":1737614741000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001258"}},"subtitle":[],"editor":[{"given":"Arnold","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,12,5]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2007,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001258","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,5]]}}}